Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Methylprednisolone and Mycophenolate mofetil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hepatitis
1 trial -
Metronidazole
Hospital Authority, Hong Kong
Helicobacter Pylori Infection
1 trial -
Metronidazole vaginal suppositories
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bacterial Vaginosis
1 trial -
MgSO4 plus Ropivacaine
Hospital Authority, Hong Kong
Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block
1 trial -
Micafungin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aspergillosis
1 trial -
Mifepristone tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uterine Fibroid
1 trial -
Minocycline
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
2 trials -
Minoxidil lotion 1%
Hospital Authority, Hong Kong
Eyebrow Hypotrichosis
1 trial -
Minoxidil lotion 2%
Hospital Authority, Hong Kong
Hypotrichosis of Eyebrows
1 trial -
Misoprostol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Labor
1 trial -
Mobile Surgical Vehicle Echocardiography-guided ASD closure Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ASD - Atrial Septal Defect
1 trial -
Montelukast
The First People's Hospital of Lianyungang
Sinusitis
1 trial -
Moxonidine 0.2 MG
Hospital Authority, Hong Kong
Central Sympathetic Nervous System Diseases
1 trial -
N-acetycysteine (600mg twice daily)
Kwong Wah Hospital
COPD
1 trial -
Nafamostat mesilate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Naldebain
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Pain
1 trial -
Nerve block with liposomal bupivacaine and intravenous analgesia
The First People's Hospital of Lianyungang
Liposomal Bupivacaine
1 trial -
NextDose (nextdose.org)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thrombosis Embolism
1 trial -
Nicorandil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stable Angina
1 trial -
Nicorandil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-obstructive Coronary Artery Disease
1 trial -
Nicorandil 5mg tid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Bypass Graft
1 trial -
Nifedipine GITS
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Nocardia rubra Cell Wall Skeleton
The First People's Hospital of Lianyungang
Diabetic Foot Ulcer
1 trial -
Norepinephrine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Septic Shock
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources